Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT06971627
Recruiting Not applicable

Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

NCT06971627 · tracked via the Priya Life Science Turkey tracker
Sponsor
Istanbul University - Cerrahpasa
Phase
Not applicable
Started
2024-04-20
Last updated
2025-05-14

Condition(s) studied

Inflammatory Bowel Disease (IBD)Medication ComplianceQuality of LifeTelehealth Monitoring

Investigational drug(s) / intervention(s)

Nurse-led Telehealth Monitoring ProgramNo intervention

Nurse-led Telehealth Monitoring Program: Participants in the intervention group will be included in a structured telehealth monitoring program led by a nurse for 12 weeks.

No intervention: Participants in the control group will only receive standard care. No additional interventions will be implemented during the 12-week period.

Study summary

This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Individuals aged 18 years or older * Individuals aged 18 years or older * Able to read and write in Turkish * Diagnosed with inflammatory bowel disease (IBD) for at least 6 months * In clinical remission (Harvey-Bradshaw Index score \< 5 or Simple Clinical Colitis Activity Index score \< 3) * Able to use a smartphone * Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address * Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom) * Willing to participate in the study voluntarily Exclusion Criteria: * Diagnosed with any psychiatric or cognitive disorder * Having any condition that impairs communication * Pregnant women * Patients receiving infusion-based treatment * Having an advanced chronic disease

Primary outcome measure(s)

  • Change in Medication Adherence Report Scale (MARS) scores — Baseline (Week 0) and 12 weeks (3 months) following telehealth monitoring.
    This scale assesses self-reported medication adherence behavior. The outcome will evaluate the change in MARS scores from baseline to week 12 to determine the impact of the telehealth intervention on adherence.

Trial sites (1)

FacilityCityRegionStatus
Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology Istanbul Turkey (Türkiye) Recruiting

More Istanbul University - Cerrahpasa trials in Turkey

Postoperative Residual Neuromuscular Block and Passive Smoke Exposure in Pediatric Dental Patients Starting soon
Evaluation of Upper Extremity Functions in Obesity Hypoventilation Syndrome Patients Starting soon
Evaluation of the Effectiveness of the Pecha Kucha-Supported Microteaching Method in Nursing Process Education Active, not recruiting
Effect of Health Promotion Model-Based Oculomotor Exercise Program on Sleep Quality in Older Adults Starting soon
Validity and Reliability of the Exergame Enjoyment Questionnaire (EEQ) in Turkish Starting soon

Other trials for the same condition

The Effect of Art-Based Intervention on Fatigue, Anxiety, Perception of Nurse Presence, and Quality of Life in Patients With Hematological Cancers Starting soon
Effects of Physical Activity Training on Physical Fitness and Quality of Life in Paramedic Students Active, not recruiting
Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients Active, not recruiting
Mindfulness-Based Education For Women With Polycystic Ovary Syndrome Recruiting
Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: a PLISSIT Model Study Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06971627 on ClinicalTrials.gov ↗ ← All trials in Turkey